ALAR vs. ADMA
ALAR (Alarum Technologies Ltd.) and ADMA (ADMA Biologics, Inc.) are both stocks. ALAR operates in Software - Infrastructure (Technology), while ADMA operates in Biotechnology (Healthcare). Over the past 5 years, ALAR returned -9.94%/yr vs 34.37%/yr for ADMA. At a 0.12 correlation, their price movements are largely independent.
Performance
ALAR vs. ADMA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ALAR achieves a 11.89% return, which is significantly higher than ADMA's -55.81% return.
ALAR
- 1D
- 7.74%
- 1M
- 15.80%
- YTD
- 11.89%
- 6M
- 20.60%
- 1Y
- 18.37%
- 3Y*
- 59.63%
- 5Y*
- -9.94%
- 10Y*
- —
ADMA
- 1D
- 1.13%
- 1M
- -1.35%
- YTD
- -55.81%
- 6M
- -58.43%
- 1Y
- -60.89%
- 3Y*
- 28.26%
- 5Y*
- 34.37%
- 10Y*
- 1.08%
ALAR vs. ADMA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
ALAR Alarum Technologies Ltd. | 11.89% | -19.13% | 36.73% | 223.33% | -66.20% | -50.00% | -53.14% | -94.90% | -80.59% |
ADMA ADMA Biologics, Inc. | -55.81% | 6.36% | 279.42% | 16.49% | 175.18% | -27.69% | -51.25% | 67.36% | -61.94% |
Correlation
The correlation between ALAR and ADMA is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.06 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.12 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.13 |
Correlation (All Time) Calculated using the full available price history since Aug 7, 2018 | 0.12 |
Fundamentals
ALAR:
$56.93M
ADMA:
$1.93B
ALAR:
$0.15
ADMA:
$0.68
ALAR:
63.27
ADMA:
11.91
ALAR:
1.60
ADMA:
3.86
ALAR:
1.71
ADMA:
4.95
ALAR:
$45.33M
ADMA:
$509.86M
ALAR:
$26.25M
ADMA:
$312.42M
ALAR:
$2.16M
ADMA:
$218.74M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ALAR vs. ADMA — Risk / Return Rank
ALAR
ADMA
ALAR vs. ADMA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Alarum Technologies Ltd. (ALAR) and ADMA Biologics, Inc. (ADMA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ALAR | ADMA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.33 | ||
| Sortino ratioReturn per unit of downside risk | +2.82 | ||
| Omega ratioGain probability vs. loss probability | 1.13 | 0.77 | +0.36 |
| Calmar ratioReturn relative to maximum drawdown | 0.28 | -0.94 | +1.21 |
| Martin ratioReturn relative to average drawdown | 0.45 | -1.81 | +2.26 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ALAR | ADMA | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.21 | -1.12 | +1.33 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.10 | 0.58 | -0.68 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.02 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.50 | -0.01 | -0.49 |
Drawdowns
ALAR vs. ADMA - Drawdown Comparison
The maximum ALAR drawdown since its inception was -99.95%, which is greater than ADMA's maximum drawdown of -91.28%. Use the drawdown chart below to compare losses from any high point for ALAR and ADMA.
Loading charts...
Drawdown Indicators
| ALAR | ADMA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.95% | -91.28% | -8.67% |
Max Drawdown (1Y)Largest decline over 1 year | -67.10% | -65.25% | -1.85% |
Max Drawdown (3Y)Largest decline over 3 years | -87.82% | -68.99% | -18.83% |
Max Drawdown (5Y)Largest decline over 5 years | -90.44% | -68.99% | -21.45% |
Max Drawdown (10Y)Largest decline over 10 years | — | -86.11% | — |
Current DrawdownCurrent decline from peak | -99.69% | -67.12% | -32.57% |
Average DrawdownAverage peak-to-trough decline | -95.63% | -53.05% | -42.58% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 41.31% | 33.62% | +7.69% |
Volatility
ALAR vs. ADMA - Volatility Comparison
Alarum Technologies Ltd. (ALAR) has a higher volatility of 35.72% compared to ADMA Biologics, Inc. (ADMA) at 11.89%. This indicates that ALAR's price experiences larger fluctuations and is considered to be riskier than ADMA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ALAR | ADMA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 35.72% | 11.89% | +23.83% |
Volatility (6M)Calculated over the trailing 6-month period | 55.15% | 45.36% | +9.79% |
Volatility (1Y)Calculated over the trailing 1-year period | 86.79% | 54.73% | +32.06% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 96.97% | 59.46% | +37.51% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 104.86% | 69.05% | +35.81% |
Dividends
ALAR vs. ADMA - Dividend Comparison
Neither ALAR nor ADMA has paid dividends to shareholders.
Financials
ALAR vs. ADMA - Financials Comparison
This section allows you to compare key financial metrics between Alarum Technologies Ltd. and ADMA Biologics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ALAR vs. ADMA - Profitability Comparison
ALAR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Alarum Technologies Ltd. reported a gross profit of 7.23M and revenue of 11.71M. Therefore, the gross margin over that period was 61.7%.
ADMA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, ADMA Biologics, Inc. reported a gross profit of 80.75M and revenue of 114.49M. Therefore, the gross margin over that period was 70.5%.
ALAR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Alarum Technologies Ltd. reported an operating income of 809.00K and revenue of 11.71M, resulting in an operating margin of 6.9%.
ADMA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, ADMA Biologics, Inc. reported an operating income of 58.27M and revenue of 114.49M, resulting in an operating margin of 50.9%.
ALAR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Alarum Technologies Ltd. reported a net income of 593.00K and revenue of 11.71M, resulting in a net margin of 5.1%.
ADMA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, ADMA Biologics, Inc. reported a net income of 45.33M and revenue of 114.49M, resulting in a net margin of 39.6%.
Frequently Asked Questions
ALAR and ADMA have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ALAR has higher volatility (35.72%) compared to ADMA (11.89%). In terms of maximum drawdown, ALAR dropped -99.95% vs ADMA's -91.28%.
ALAR currently has the higher Sharpe Ratio (0.21 vs -1.12), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ALAR and ADMA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer